Insight on licensing deal of Pfizer and The Medicines Patent Pool for COVID-19 Oral Antiviral Treatment Candidate to Expand market Access in Low- and Middle-Income Countries
Posted on18 Nov 2021
Comments0
Pfizer and the Medicines Patent Pool (MPP), a United Nations-backed public health organization working to increase access to life-saving medicines for low-... Read More
Insignt on Takeda and Biological E. Ltd (BE) licensing agreements for vaccines
Takeda Pharmaceutical Company (Takeda) and Biological E. Ltd (BE) have entered into a collaboration whereby two licensing agreements to expedite the development... Read More
A case of licensing mega deal : Sanofi – Hanmi Pharmaceutical for the development of investigational diabetes medicines
Posted on06 Nov 2015
TagsA case of pharma licensing mega deal, drug licensing, efpeglenatide, Globalpharma sanofi, GLP-1 Receptor Agonists, GLP1-agnostics, Hanmi Pharmaceutical, inlicensing in pharma, Sanofi, Sanofi - Hanmi Pharmaceutical for the development of investigational diabetes medicines
Comments0
South Korean pharmaceutical company Hanmi Pharmaceutical Co. said Thursday that it has reached a license agreement with global drugmaker Sanofi to develop... Read More